Tech
Moderna Shares Plunge After Leak of Cancer Vaccine Data
Moderna shares plunged as much as 25% after partial clinical trial data leaked for its personalized cancer vaccine developed with Merck, despite the full results showing…
Discussion (0)
No comments yet. Start the conversation!